Form S-1/A CATALYST BIOSCIENCES,
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 7/28/2026
- Wall Street ends mixed as investors focus on tech earnings
- Nvidia in talks with OpenAI to guarantee $250 billion financing for data center, WSJ reports
- ASML and U.S. chip stocks sink on report of China’s DUV breakthrough
- Why is Bernstein bullish on memory stocks after Samsung, Nvidia deals?
- Oil prices settle at lowest in over a week, as US pauses attacks on Iran
- BTIG Upgrades Outlook Therapeutics Inc. (OTLK) to Buy
- Applied Digital (APLD) Tops Q4 EPS by 23c, Revenue Beats
- Carpenter Technology CEO Brian Malloy passes; Tony Thene returns as CEO
- ASML and U.S. chip stocks sink on report of China’s DUV breakthrough
- BuzzFeed cuts 35% of workforce in restructuring move
Catalyst Biosciences (CBIO) Prices Common Stock and Warrant Offering for Gross Proceeds of $18M
April 7, 2017 8:40 AM EDTCatalyst Biosciences, Inc. (NASDAQ: CBIO), a clinical-stage biopharmaceutical company focused on developing novel medicines to address hematology indications, today announced the pricing of an underwritten public offering of units for gross proceeds of $18 million, prior to deducting underwriting discounts and commissions and offering expenses payable by Catalyst.
The offering is comprised of Class A Units, priced at a public offering price of $5.00 per unit, with each unit consisting of one share of common stock and a five-year warrant (each, a warrant) to purchase one-half share of common stock with an... More
Catalyst Biosciences (CBIO) Set to Open Lower
April 7, 2017 6:46 AM EDTCatalyst Biosciences (NASDAQ: CBIO) was set to open sharply lower Friday morning following an effective notice from the SEC regarding its recent S-1.
UNITED STATESSECURITIES AND EXCHANGE COMMISSIONWashington, D.C. 20549Notice of EffectivenessEffectiveness Date:April 6, 2017 5:00 P.M.Form:S-1CIK:0001124105Company Name:CATALYST BIOSCIENCES, INC.File Number:333-216663... More